Skip subpage navigation
| Meeting Date |
Drug Classes Under Review/Information for Manufacturers |
| February 2012 |
- ADHD/Narolepsy
- Anti-platelet Therapy
- Diabetes: Non-Insulin
New Drugs
|
| May 2012 |
- Sedative/Hypnotic
- Tobacco Cessation Drugs
New Drugs
|
| August 2012 |
- Androgens-Anabolic Steroids
- Anticoagulants
New Drugs
- Bydureon
- Duesis
- Janumet XR
- Jentadueto
- Orencia
- Sprix
- Zioptan
|
| November 2012 |
- Hepatitis C Agents
- Overactive Bladder Agents
- Gastrointestinal-2 Agents
- Diabetes: Non-Insulin
New Drugs
|
You are leaving Health.mil
The appearance of hyperlinks does not constitute endorsement by the Department of Defense of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.
You are leaving Health.mil
View the external links disclaimer.
Last Updated: April 25, 2024